Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trimodality Management of T1b Esophageal Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
- Status
- COMPLETED
- Phase
- NA
Amrubicin (AMR) Trial in Patients With Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Erlotinib [Tarceva] as Monotherapy or Intermittent Dosing With Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer. (TALISMAN)
- Status
- COMPLETED
- Phase
- PHASE2
Study of PX-866 and Docetaxel in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel
- Status
- COMPLETED
- Phase
- PHASE1
1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2
- Status
- COMPLETED
- Phase
- N/A
Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2